Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	95.47	-125.31	64.11
Graham Fair Price	14.64	17.86	15.58
PEG	-50.75	0.24	-0.48
Price/Book	-28.67	0.79	1.11
Price/Cash Flow	-91.62	20.20	-241.20
Prices/Earnings	-46.64	7.92	14.84
Price/Sales	-26.91	5.36	7.33
Price/FCF	-91.62	20.20	-241.20
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.96	0.93	0.91
Operating Margin	78.83	0.30	0.17
ROA	32.53	< 0.005	< 0.005
ROE	0.02	0.03	33.67
ROIC	< 0.005	0.02	75.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.04	-54.26
Dividends QOQ	< 0.005	< 0.005	902.50
EBIT QOQ	-0.31	0.73	136.69
EPS QOQ	-0.31	0.33	8.33
FCF QOQ	-1.07	9.45	787.37
Revenue QOQ	0.44	-0.03	-92.89
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-5345.16	-6984.31	-30.67
Days Sales Outstanding (DSO)	205.58	209.46	1.89
Inventory Turnover	-0.02	-0.01	23.47
Debt/Capitalization	0.48	0.48	-1.06
Quick Ratio	0.39	0.38	-1.68
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	24.01	23.80	-0.84
Cash	52.83	51.92	-1.72
Capex	-0.41	-0.03	93.11
Free Cash Flow	-0.11	0.93	744.40
Revenue	3.64	3.52	-3.23
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.07	0.07	0.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.42	-48.30	136.55
Naive Interpretation	Member

06 - Financial Health · Bad

Rating